Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Wenhong Shen"'
Autor:
Xuanqi Cao, Haiping Dai, Qingya Cui, Zheng Li, Wenhong Shen, Jinlan Pan, Hongjie Shen, Qinfen Ma, Mengyun Li, Sifan Chen, Juncheng Chen, Xiaming Zhu, Huimin Meng, Lin Yang, Depei Wu, Xiaowen Tang
Publikováno v:
Experimental Hematology & Oncology, Vol 11, Iss 1, Pp 1-5 (2022)
Abstract Relapsed/refractory acute myeloid leukemia (AML) patients generally have a dismal prognosis and the treatment remains challenging. Due to the expression of CD7 on 30% AML and not on normal myeloid and erythroid cells, CD7 is an attractive ta
Externí odkaz:
https://doaj.org/article/131d1295c28b4fa7ae29c0ff1a185f32
Autor:
Qingya Cui, Chongsheng Qian, Nan Xu, Liqing Kang, Haiping Dai, Wei Cui, Baoquan Song, Jia Yin, Zheng Li, Xiaming Zhu, Changju Qu, Tianhui Liu, Wenhong Shen, Mingqing Zhu, Lei Yu, Depei Wu, Xiaowen Tang
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-5 (2021)
Abstract Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment for acute myeloid leukemia (AML). However, most patients experience relapse after allo-HSCT, with a poor prognosis, and treatment options are
Externí odkaz:
https://doaj.org/article/cc14e2093e194871ac3d015e17b11a2e
Publikováno v:
ACS Omega. 7:15507-15517
With energy savings and emission reduction becoming national policies in recent years, the environmental impacts of industrial production are more and more critical. Most of the studies have concentrated on the environmental effects of the industrial
Autor:
Yan Chen, Qian Wang, Jiannong Cen, Chao Xu, Ting‐ting Tao, Jundan Xie, Wenhong Shen, Yanlei Gong, Jinlan Pan, Li Yao
Publikováno v:
Molecular carcinogenesisREFERENCES.
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm defined by the presence of t(9;22)(q34;q11.2)/BCR::ABL1. Additional chromosomal abnormalities play an important role in the progression to CML. However, the additional fusion gene was ra
Autor:
Jiaqian Qi, Xin Lv, Jia Chen, Hong Wang, Tiantian Chu, Yaqiong Tang, Tingting Pan, Meng Zhou, Chengsen Cai, Yuan Ren, Yuejun Liu, Yi Fan, Wenhong Shen, Xiao Ma, Huiying Qiu, Xiaowen Tang, Chengcheng Fu, Depei Wu, Yue Han
Publikováno v:
Hematological Oncology. 40
Autor:
Wenhong Shen, Chengsen Cai, Yuejun Liu, Jia Chen, Xiaowen Tang, Huiying Qiu, Tingting Pan, Yi Fan, Jiaqian Qi, Meng Zhou, Yuan Ren, Yaqiong Tang, Xin Lv, Depei Wu, Xiao Ma, Tiantian Chu, Yue Han, Hong Wang, Chengcheng Fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4915f8be20db1a00126ac549774dc321
https://doi.org/10.1002/hon.2931/v2/response1
https://doi.org/10.1002/hon.2931/v2/response1
Autor:
Tiantian Chu, Hong Wang, Huiying Qiu, Yuan Ren, Depei Wu, Chengsen Cai, Yue Han, Yuejun Liu, Xiaowen Tang, Yi Fan, Meng Zhou, Chengcheng Fu, Yaqiong Tang, Xiao Ma, Wenhong Shen, Xin Lv, Tingting Pan, Jiaqian Qi, Jia Chen
Publikováno v:
Hematological oncologyREFERENCES. 40(1)
Chimeric antigen receptor (CAR) T-cell therapy has shown excellent clinical efficacy in patients with hematologic malignancies. However, severe bleeding after this treatment is a life-threatening complication for most patients. This study evaluated t
Autor:
Changju Qu, Xiaming Zhu, Zheng Li, Wei Cui, Qingya Cui, Haiping Dai, Lei Yu, Chongsheng Qian, Liqing Kang, Nan Xu, Jia Yin, Baoquan Song, Wenhong Shen, Ming-Qing Zhu, Depei Wu, Xiaowen Tang, Tianhui Liu
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-5 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment for acute myeloid leukemia (AML). However, most patients experience relapse after allo-HSCT, with a poor prognosis, and treatment options are limited.
Autor:
Jiaqian Qi, Xin Lv, Jia Chen, Hong Wang, Tiantian Chu, Yaqiong Tang, Tingting Pan, Meng Zhou, Chengsen Cai, Yuan Ren, Yuejun Liu, Yi Fan, Wenhong Shen, Xiao Ma, Huiying Qiu, Xiaowen Tang, Chengcheng Fu, Depei Wu, Yue Han
Backgroud: Chimeric antigen receptor (CAR) T-cell therapy has shown excellent clinical efficacy in patients with hematologic malignancies. However, severe bleeding after this treatment is a life-threatening complication for most patients. Objectives:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b547f051bcf966d3d38d0a2e99df9a3
https://doi.org/10.21203/rs.3.rs-108274/v1
https://doi.org/10.21203/rs.3.rs-108274/v1
Autor:
Rui Zhang, Yue Han, Wenhong Shen, Yaqiong Tang, Hong Wang, Chengsen Cai, Tingting Pan, Jiaqian Qi, Meng Zhou, Depei Wu
Publikováno v:
Annals of hematology. 100(9)
Severe bleeding is a major cause of death in acute leukemia (AL) patients with graft-versus-host disease (GVHD) after allogene hematopoietic stem-cell transplantation (allo-HSCT). However, the prognostic value and prediction of HSCT-associated severe